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The Molecular Basis of X^Linked Deafness Type 3
(DFN3) in Two Sporadic Cases: Identification of a 
omatic Mosaicism for a POU3F4 Missense Mutation
Yvette J.M. de Kok,1 Cor W.RJ. Cremers,2 Hans^Hilger Ropers,1 and Frans P.M. Cremers1*
/ Department of Human  Genetics, University Hospital Nijmegen, 65ÖÖ HB Nijmegen, the Netherlands; Fax: 31-24-3540488 
“Department of Otorhinolaryngology, University Hospital Nijmegen, 6500 HB Nijmegen, the Netherlands
Communicated by Jean^Jumis Mandel
We have investigated two unrelated males with X-linked deafness type 3 (DFN3) for mutations in the 
POU3F4 gene. In one patient, we observed a mutation that is predicted to result in an Arg330Ser 
amino acid substitution. In another DFN3 patient, a somatic mosaicism for an Arg323GIy amino acid 
substitution was found» This mosaicism was detected in two independently established EBV immortal' 
ized B cells and peripheral blood lymphocytes (PBLs) * Semiquantitative analysis showed that approxi­
mately 50% of the PBLs of this patient carry the mutation. We hypothesize that the Arg323Gly mutation 
occurred very early in embryogenesis, before the differentiation of cells involved in hematopoiesis and 
inner ear development In both patients, the missense mutations are situated in the POU homeodomain 
and are predicted to disrupt the DNA binding of the POU3F4 protein. All nine point mutations thus 
far described were found in the POU domains ofPOU3F4* Since these domains constitute only 35% of 
the open reading frame of POU3F4j there is a statistically significant preference for mutations in the 
POU-specific and POU homeodomain. Hum Mutat 10:207-211, 1997. © 1997 Wiley-Uss, Inc.
KEYWORDS: X-linked deafness type 3; POU3F4 missense mutation; POU homeodomain
INTRODUCTION
X-Linked deafness type 3 (DFN3) is characterized 
by an abnormally wide opening in the bone separat­
ing the basal turn of the cochlea and the inner audi­
tory meatus, a fixation of the stapes, and a perilymphatic 
gusher upon stapedectomy (Cremers et al., 1983; Phelps 
et al., 1991). Affected males either have mixed deaf­
ness or, less commonly, only sensorineural deafness. 
In the latter situation, the conductive element is 
masked by the sensorineural deafness. An accurate 
physical localization of the DFN3 gene was achieved 
by the molecular characterization of various deletions
associated with DFN3 (Huber etal., 1994)- Recently,
positional candidate gene cloning resulted in the
identification of the DFN3 gene, POU3F4 (de Kok 
et al., 1995). POU3F4 is a member of a gene family
of transcription factors that contain two conserved 
domains, a POU-specific and a POU homeodomain. 
Small mutations were found in the human POU3F4 
gene in 7 unrelated patients with familial DFN3 (de 
Kok etal., 1995; Bitner-Glindzicz etal., 1995). Here,
we report on the identification of point mutations in
the POU3F4 gene in two sporadic cases of DFN3,
one of which shows a somatic mosaicism.
MATERIALS AND METHODS 
DFN3 Patients
Patient 1186 (F.B.) is a 44-year-old man who suf­
fered from a progressive hearing loss. At the age of 7 
he was obese, had growth retardation, and experi­
enced intermittent diarrhea. He had an exploratory 
tympanotomy at the age of 18 because of presumed 
otosclerosis (Cremers et al., 1983). Upon stapedec­
tomy, a perilymphatic gusher was encountered. 
Polytomography showed dilation of the semicircular 
canals and of the lateral part of the IAM. In addition 
to the hearing loss, patient 1186 shows hyperparathy­
roidism and subclinical hypothyroidism. The latter 
symptoms are probably due to the multiple endocrine 
adenomatosis type 1 syndrome found in his father, 
two of his aunts, three nieces, and a cousin. No other 
members of his family exhibited hearing loss.
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Patient 1185 (A.M.) had a history of mixed hear­
ing loss dating back to the age of 6 years. At the age 
of 56 years, he underwent a stapedectomy, upon 
which a perilymph gusher was encountered (Cremers 
et al, 1983). Polytomography of the petrous bones in 
the axial-pyramidal and the Guillen view was normal. 
The patient died in 1994 because of a lung carcinoma. 
Genealogical examination did not display any evidence 
for consanguinity in his family for five generations.
DNA Scqucnce Analysis
Genomic DNA isolation from Epstein-Barr virus 
(EBV)-immortalized lymphocytes and peripheral 
blood lymphocytes (PBLs) was performed as described
(Huber et al., 1994), For patients 1185 and 1186,
segments of the POU3F4  gene were amplified by 
PCR, gel purified, and sequenced as published else­
where (de Kok et al., 1995).
Hybridization of Allele-Specific Oligonucleotides
PCR products generated from DNA of patient 1185 
by primers Va (5 ' -CATTGACAAGATCGCTGCAC- 
3 ')  and Vb (5 '-GCCTCCTCGCTTCCTCCA^3')
were cloned in the Smal site of pBluescript (SK-). 
Eight clones were sequenced, three of which showed 
the mutant sequence. Next, segment V (nucleotides
804-1105) of the POU3F4  gene (de Kok e ta l ,  1995)
was amplified employing DNA isolated from PBLs of 
patient 1185, a control male, and from cloned mu­
tant segment V. The PCR products were analyzed 
on an agarose gel and quantitated spectrophoto- 
metrically. Serial twofold dilutions (4, 2, and 1 ng) 
of the 302-bp fragment were applied to a nylon 
filter (GenescreenPlus, NEN) according to the 
manufacturer’s protocol using a dot-blot apparatus. 
Duplicate filters were prepared for each sample, 
prehybridized for 4 hr in 5 X SSPE/0,3% sodium dode- 
cyl sulfate (SDS), and then hybridized overnight at 
52°C in the same buffer with either the mutant (5
GGAAGTGGTG GGTGTCTGGTT-3 ') or the nor­
mal (5 '-GGAAGTGGTGCGTGTCTGGTT*3y)
oligonucleotides end-labeled withy-32P-ATP to a spe­
cific activity of 5 X 108 dpm/|lg. The filters were 
washed 2 X 15 min in 5 X SSPE/0.3% SDS at 68°C 
and exposed to 3-6 hr. Quantitation of the signal 
was carried out employing the Hewlett Packard 
ScanJet lie densitometer. The relative frequencies of 
the mutant and wild-type POU3F4  alleles in patient 
1185 were calculated by comparing the densities of 
the dots with those of mutant and normal PCR prod­
ucts in four independent experiments. Next, the fil­
ters were stripped in 0.1 X SSC/0.1% SDS and 
hybridized with primer Va as described above for the 
other oligonucleotide.
RESULTS
Identification of POU3F4 Point Mutations in 
DFN3 Patients 1185 and 1186
Genomic DNA of EBV immortalized B cells of the 
DFN3 patients 1185 and 1186 was amplified using 
five primer pairs that together permit analysis of the 
complete open reading frame of the intronless
POU3F4  gene (de Kok et al, 1995). Employing prim­
ers Va and Vb, which amplify a 302-bp fragment (seg­
ment V) encompassing the POU homeodomain, we 
found an A-to-T transversion at nucleotide position 
990 in patient 1186. This mutation is predicted to 
result in a substitution of a serine for an arginine resi­
due at amino acid position 330 (results not shown). 
In patient 1185, we found a mixture of the normal C 
and a mutant G at nucleotide position 967 (Fig. la). 
The mutation replaces a glycine for an arginine resi­
due at position 323. This mutation was also identi­
fied in the DNA of another independently established 
EBV cell line of DFN3 patient 1185, as well as in his 
PBLs (data not shown).
To rule out the possibility of a duplication of the 
POU3F4 gene followed by a point mutation in 
POU3F4, we hybridizedPOL/3F4 on a Southern blot 
containing EcoRI-digested PBL DNA of patient 1185 
and a control male. The hybridization signal of 
POU3F4  iii patient 1185 was comparable to that in
the control mate, excluding a duplication (data not 
shown). Since the mutant/wild-type nucleotide ra­
tio cannot be estimated by comparing the respective 
fluorescence peaks, we performed dot-blot analysis 
employing allele-specific oligonucleotides.
Semiquantitative Analysis of the Somatic 
Mosaicism Employing Allele-Specific 
Oligonucleotide Hybridization
We amplified segment V of the POU3F4  gene
employing DNA derived from PBLs from patient 
1185, a male control, and cloned mutant DNA. Se­
rial dilutions of these three samples were immobi- 
lized on nylon membranes hybridized with P-labeled 
21-mers containing the mutant or the normal se­
quence (Fig* lb, top). Subsequently, the membranes 
were stripped and rehybridized with 32P-labeled primer 
Va, one of the primers used to amplify the PCR prod­
ucts (Fig. lb, bottom). Hybridization with primer Va 
clearly shows that equal amounts of the PCR prod­
ucts were blotted on the membrane. Under the con­
ditions employed, the mu t an t  and wild-type 
oligonucleotides hybridized specifically to their ho­
mologous PCR products (Fig, lb, top). As expected 
from the nucleotide sequence analysis, both primers 
hybridize to PCR products from patient 1185. Next, 
by employing densitometry, we compared the inten-
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perilymphatic gusher) during stapes mobilization. The 
fact that no temporal bone defect was found in pa­
tient 1185 might be due to the inadequate resolu­
tion of the poly tomography technique that was used 
to investigate the temporal bone compared to the 
high-resolution computed tomography (CT) studies 
performed more recently, CT scanning cannot be 
performed, as the patient is deceased.
Females carrying a DFN3 mutation show a vari­
able phenotype, ranging from asymptomatic to a
moderate hearing loss (Nance et al., 1971; Thorpe 
et al., 1974; Cremers and Huygen, 1983). This sug­
gests a not yet formally proven functional mosaicism 
due to random X-inactivation of the normal POU3F4 
gene. O n  average, X-inactivation in female carriers
results in inactivation of the POU3F4  gene in 50% 
of somatic cells, comparable to the somatic mosa­
icism observed in the PBLs of patient 1185. How­
ever, since patient 1185 shows at least two of the 
characteristic features of DFN3, it seems more likely 
that the mesodermal precursor cells of the temporal 
bone contain a higher percentage of cells with the 
Arg323Gly mutation.
Including the mutations reported in this study, 
nin~e point mutations have been identified in DFN3 
patients, invariably located in the POU domains of 
POU3F4-  Four stop mutations reside in the POU 
specific or POU homeodomain; five missense muta­
tions are located in the POU homeodomain (de Kok
et al., 1995; Bitner-Glindzicz et al., 1995)* The com­
plete POU domain constitutes 35% of the ORF, in­
dicating a statistically significant preference for 
mutations in these regions (P <  0.0001 for the POU 
domain). There should be no a priori preference for 
stop mutations in a given domain of POU3F4, since 
any stop mutation upstream of the POU domains 
would be predicted to have the same result as stop 
mutations in the POU domains, i.e. loss of function 
of the protein. The clustering of missense mutations 
in the POU homeodomain might be explained by the 
assumption that mutations of this type in other parts 
of the protein result in a completely different pheno­
type or in no phenotype at all. The latter possibility 
seems less probable, since orthólogous POU3F4  genes 
in mouse, rat, and human are highly conserved (Hara 
et a l ,  1992; Le Moine and Young, 1992; de Kok et al. 
1995). Apart from the developing inner ear, the 
POU3F4  gene is transiently expressed in the fetal 
rat brain and developing neural tube (Le Moine and
Young, 1992), mouse pituitary gland (Schonemann 
et aL, 1995), and hum an fetal brain and fetal kid­
ney (S.M. van der Maarel, Y.J.M. de Kok, and 
F.EM. Cremers, unpublished results). As shown 
for Oct-1 and O ct-2, POU proteins cooperate with
a myriad of transcription factors including other 
POU domain proteins, in order to confer cell type- 
specific expression of target genes (Veenstra et al., 
in press). Possibly, POU3F4 proteins carrying mis­
sense mutation outside the POU homeodomain 
might interact erroneously with vital transcription 
factors in some of these tissues, resulting in em­
bryonic lethality.
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